Alector (NASDAQ:ALEC) said AbbVie (NYSE:ABBV) has sent written notice that it is terminating the TREM2 program, the last ...
Abbvie said on Friday it would record a charge of about $3.5 billion related to its experimental schizophrenia drug, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback